Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.

about

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.

Item

http://www.wikidata.org/entity/Q47136441

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@en

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@nl

type

Item

label

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@en

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@nl

prefLabel

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@en

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@nl

P1476

Gene Mutations as Emerging Bio ...... lapsed Acute Myeloid Leukemia.

@en

P2093

Chow Y Ping

http://www.w3.org/2001/XMLSchema#string

Habsah Aziz

http://www.w3.org/2001/XMLSchema#string

Hamidah Alias

http://www.w3.org/2001/XMLSchema#string

Nurul-Syakima Ab Mutalib

http://www.w3.org/2001/XMLSchema#string

Rahman Jamal

http://www.w3.org/2001/XMLSchema#string

P2860

BCoR, a novel corepressor involved in BCL-6 repression

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Recurring mutations found by sequencing an acute myeloid leukemia genome

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Cohesin and its regulation: on the logic of X-shaped chromosomes

DNMT3A Mutations in Acute Myeloid Leukemia

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

P304

897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FPHAR.2017.00897

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29270125

http://www.w3.org/2001/XMLSchema#string

P932

5725465

http://www.w3.org/2001/XMLSchema#string